Analysis Type: Exome Analysis

Exome Analysis Software for Clinical Diagnostics

Streamline your whole exome sequencing (WES) workflows. From alignment and variant calling to ACMG classification and clinical reporting, VarSeq provides the end-to-end solution for clinical laboratories.

ISO 13485 Certified QMS
CAP/CLIA Ready
CE Marked (IVDR)

Mastering Whole Exome Sequencing Analysis

Clinical laboratories require a robust, reproducible, and auditable pipeline for exome analysis software. VarSeq simplifies the transition from FASTQ to clinical report, eliminating the complexities of custom bioinformatics scripts.

1

Secondary Analysis Integration

Powered by Sentieon's optimized implementation of GATK models, achieve mathematically equivalent results with massive throughput gains. Sentieon DNAscope provides improved accuracy through enhanced active region detection, powerful local assembly, and pre-trained machine learning models.

Sentieon Integration Details
2

Variant Annotation & Filtering

Real-time filter chains allow for the systematic reduction of thousands of variants to a manageable list of clinically significant candidates. Leverage industry-leading databases including ClinVar, OMIM, and ClinGen.

Explore Annotation Sources
3

Clinical Interpretation (ACMG/AMP)

VSClinical guides analysts through the ACMG/AMP classification framework, providing transparent reasoning and automated scoring for every variant. Consistently classify findings as Pathogenic, Likely Pathogenic, or VUS.

Classification Workflow
Exome Filter Chain
38,247
Zygosity (Current) is (Heterozygous, Homozygous)
24,891
Genotype Qualities (GQ) (Current) ≥ 30
22,104
gnomAD AF < 0.01 OR Missing
1,847
Predicted Function is (Missense, Nonsense, Frameshift, ...)
412
ClinVar Classification & ACMG Auto-Score
Benign298
Likely Benign84
VUS22
Likely Pathogenic2
Pathogenic1
Final variants
3
Exome Trio Analysis
Rare Disease
Father
Mother
Proband
SCN1A c.1234A>G (p.Arg412Gly)Pathogenic
De NovoNot present in either parent

Missense in sodium channel gene. Associated with Dravet syndrome. ClinVar: Pathogenic (reviewed by expert panel).

USH2A Compound HeterozygousLikely Path.
Paternalc.2299delGMaternalc.11864G>A

Two heterozygous variants in trans. Usher syndrome type 2A. Phase confirmed by parental genotypes.

PhoRank phenotype match: HPO: Seizures, Intellectual disability

Advanced Trio Analysis for Rare Disease

Diagnosing rare genetic disorders requires powerful trio/quad analysis capabilities. VarSeq automates the identification of de novo mutations, autosomal recessive (including compound heterozygous) events, and X-linked inheritance patterns.

PhoRank Ranking

Prioritize variants based on phenotype-to-gene matching using HPO and OMIM terms.

Inheritance Filtering

Instantly flag variants matching family affection status and pedigree relationships.

Compound Het

Automatic detection and phase assessment of compound heterozygous variants.

Custom Reports

Generate structured reports for trio analysis with secondary findings and discussion sections.

Gene-Level Coverage Analysis

Exome capture is inherently uneven — some genes and exons consistently underperform. VarSeq provides per-gene coverage metrics so you can verify that every clinically relevant region meets your depth thresholds before reporting results.

Coding Region Coverage Reporting

Report the percentage of each gene's coding region covered at a configurable depth threshold — for exomes, typically 80x or higher — so you know exactly where gaps exist.

Critical Gene Assurance

Flag specific genes of interest — such as BRCA1, CFTR, or disease-specific gene lists — and verify adequate coverage before finalizing clinical interpretation.

Overall Exome QC

Assess overall on-target rate, mean depth, and uniformity metrics to catch library prep or capture issues before they affect downstream results.

Gene Coverage at ≥ 80x
Exome QC
On-Target Rate
87.4%
Mean Depth
112x
BRCA1100% at ≥ 80x
CFTR98.2% at ≥ 80x
PMS274.1% at ≥ 80x
SCN1A96.8% at ≥ 80x
PMS2 below 80x threshold — review exon 11-13 coverage

Enterprise Data Management & Longitudinal Tracking

Scalable genomic analysis requires more than just a workstation. VSWarehouse centralizes your variant assessments, clinical reports, and longitudinal data into a secure, searchable repository.

  • Classification change reports for classified variants
  • Cross-sample allele frequency and historical interpretations
  • Secure, versioned storage for CLIA/CAP audit readiness
Explore VSWarehouse
VSWarehouse — Enterprise Dashboard
Samples
48,291
+1,247 this month
Reports
12,834
+342 this month
Alerts
7
Reclassifications
Assessment Catalogs
Hereditary Cancer Panel4,218 variantsActive
Cardiac Arrhythmia1,892 variantsActive
Exome — Rare Disease12,461 variantsActive
3 Workspaces · 14 Active Users
SSO Enabled RBAC Active

Clinical Genomics Insights & Webcasts

Stay updated with the latest in NGS analysis, ACMG guidelines, and clinical exome implementation.

Ready to Optimize Your Exome Analysis?

Join the hundreds of clinical laboratories worldwide that trust Golden Helix for their precision medicine workflows.

ACMG Classification
Exome Ready
ISO 13485 Certified QMS